2024-11-25 from cmaj.ca
On Oct. 10, 2024, Bill C-64 — comprising the first concrete measures to implement universal, single-payer, public pharmacare in Canada — became law.1 As an initial step toward full national pharmacare, it is a laudable achievement. Yet the legislation is low on substance, high on promises and aspirations, and vulnerable to political change. This leaves people living in Canada mired in uncertainty as to when or whether they will have the guaranteed access to medications and therapies, regardless of ability to pay, that citizens of almost all other countries with a public health care system receive.
Read more here